DocDollars

Merck Sharp & Dohme LLC

NJ · United States · Reporting entity ID 100000000053

Total reported 2019–2025
$3.73B
#2 of 2,960 reporting companies — 4.5% of all reported industry payments
$176.9M in general payments across 1,481,141 records, plus $3.56B in research funding across 186,102 records.

How it breaks down

General payments $176,852,890
Research funding $3,555,156,488

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Merck Sharp & Dohme LLC reported $3.73B to US doctors and teaching hospitals from 2019 to 2025, ranking #2 of 2,960 reporting companies. 95% of that was research funding and 5% general payments such as consulting, speaking, food and travel. 1,481,141 general payment records and 186,102 research records were filed.

Common questions about Merck Sharp & Dohme LLC

How much has Merck Sharp & Dohme LLC paid US doctors?

Merck Sharp & Dohme LLC reported $3,732,009,378 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $176,852,890 in general payments, $3,555,156,488 in research funding.

How does Merck Sharp & Dohme LLC rank among drug and device companies?

It ranks #2 of 2,960 reporting entities by total reported value, about 4.5% of all industry payments in the dataset.

Does a payment from Merck Sharp & Dohme LLC mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.